Search Ontology:
ChEBI
leuprolide
- Term ID
- CHEBI:6427
- Synonyms
-
- (D-Leu(6),des-Gly-NH2(10),Pro-ethylamide(9))-gonadotropin-releasing hormone
- 5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide
- L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamide
- Leuprorelin
- leuprorelina
- leuproreline
- leuprorelinum
- pGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHC2H5
- pGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt
- Definition
- An oligopeptide comprising pyroglutamyl, histidyl, tryptophyl, seryl, tyrosyl, D-leucyl, leucyl, arginyl, and N-ethylprolinamide residues joined in sequence. It is a synthetic nonapeptide analogue of gonadotropin-releasing hormone, and is used as a subcutaneous hydrogel implant (particularly as the acetate salt) for the treatment of prostate cancer and for the suppression of gonadal sex hormone production in children with central precocious puberty.
- References
-
- CAS:53714-56-0
- DrugBank:DB00007
- Drug_Central:1559
- KEGG:C07612
- KEGG:D08113
- Patent:DE2446005
- Patent:US4005063
- Reaxys:741818
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
- is a type of
-
- has_role
-
- inverse has_part
-
Phenotype
Phenotype resulting from leuprolide
Phenotype where environments contain leuprolide
Phenotype modified by environments containing leuprolide
Human Disease Model